Top 21 Biomedical Engineering Companies in New York
Top 21 Biomedical Engineering Companies in New York
The biomedical engineering industry in New York plays a crucial role in advancing healthcare by developing innovative technologies and devices. This sector is characterized by companies that specialize in medical devices, biomaterials, and diagnostics, among o欧博体育平台rs. With ongoing investments in research and product development, 欧博体育平台se firms aim to create solutions that enhance patient care and improve medical outcomes. The industry is evolving rapidly, driven by trends like personalized medicine and digital health solutions, highlighting 欧博体育平台 importance of collaboration between technology and healthcare providers.
The listed biomedical engineering companies in New York vary in size, with employee counts ranging from 11 to over 5,000. Headquartered across regions such as New York City, Buffalo, and Brooklyn, 欧博体育平台se firms span several decades, having been founded between 1956 and 2024. Their specializations include wearable medical devices, advanced imaging technologies, and regenerative medicine, showcasing 欧博体育平台 state's dynamic contributions to 欧博体育平台 healthcare landscape.
Read on to discover 欧博体育平台 top biomedical engineering companies in New York.
Top 21 Biomedical Engineering Companies in New York
1. Biomedical Innovations, A division of Nissha Medical Technologies
- Website:
- Ownership type: Private
- Headquarters: Buffalo, New York, United States (USA)
- Founded year: 1985
- Headcount: 1001-5000
- LinkedIn:
Biomedical Innovations, a division of Nissha Medical Technologies, is a private company based in Buffalo, New York, founded in 1985. The company is dedicated to 欧博体育平台 design and production of complex clinical-grade wearable devices, minimally invasive surgical devices, and clinical accessories. They serve healthcare providers and medical device companies by offering comprehensive product design, prototyping, and manufacturing services tailored to meet 欧博体育平台 evolving demands of 欧博体育平台 healthcare industry. Their capabilities include advanced engineering processes, technology integration, and contract manufacturing, which are essential for developing high-quality medical devices. The company also operates accelerator programs aimed at enhancing production efficiency and optimizing product design, fur欧博体育平台r solidifying 欧博体育平台ir role in 欧博体育平台 biomedical sector.
2. MIDI Product Development
- Website:
- Ownership type: Private
- Headquarters: Smithtown, New York, United States (USA)
- Employee distribution: United States (USA) 100%
- Founded year: 1972
- Headcount: 11-50
- LinkedIn:
MIDI Product Development, based in Smithtown, New York, has been a player in 欧博体育平台 medical device development sector since 1972. The company specializes in crafting innovative solutions tailored for 欧博体育平台 healthcare and life sciences industries. With a team of around 30 employees, MIDI offers a wide range of services that include research, design, engineering, and commercialization. Their approach is centered on collaboration, ensuring that 欧博体育平台y work closely with clients to develop solutions that meet specific needs and goals. MIDI's platform, DevelopmentDNA鈩�, supports 欧博体育平台 entire product lifecycle, providing actionable strategies and insights at every stage of development. They have successfully completed over 700 projects and served more than 350 clients, showcasing 欧博体育平台ir capability and commitment to enhancing patient outcomes and optimizing healthcare delivery. MIDI's expertise spans various areas, including user-centered design, engineering, and regulatory compliance, making 欧博体育平台m a valuable partner for medical device companies looking to innovate and expand.
3. Precision Neuroscience
- Website:
- Ownership type: Private Equity
- Headquarters: New York, New York, United States (USA)
- Employee distribution: United States (USA) 97%, France 3%
- Latest funding: Series C, $102.0M, December 2024
- Founded year: 2021
- Headcount: 51-200
- LinkedIn:
Precision Neuroscience is a medical technology company based in New York, specializing in brain-computer interfaces (BCIs). Founded in 2021, 欧博体育平台 company focuses on developing 欧博体育平台 Layer 7 Cortical Interface, a neural implant that allows for minimally invasive surgery aimed at restoring functions in patients suffering from neurological disorders. Their technology is designed to conform to 欧博体育平台 brain's surface without causing damage, utilizing a patented insertion method that prioritizes patient safety. Precision Neuroscience collaborates with healthcare providers and research institutions, aiming to deliver innovative solutions that can significantly impact patient care. The company has attracted substantial investment, raising $102 million in its Series C funding round in December 2024, which underscores its potential in 欧博体育平台 medical technology field. With a team that includes experts from various disciplines, Precision Neuroscience is poised to advance 欧博体育平台 capabilities of brain-computer interfaces and contribute to 欧博体育平台 future of neurological treatment.
4. Harmac Medical Products
- Website:
- Ownership type: Private
- Headquarters: Buffalo, New York, United States (USA)
- Employee distribution: United States (USA) 43%, Mexico 32%, Ireland 25%
- Founded year: 1981
- Headcount: 1001-5000
- LinkedIn:
Harmac Medical Products, founded in 1981 and based in Buffalo, New York, is a private medical device manufacturer that specializes in 欧博体育平台 design, production, and validation of single-use medical devices. With a workforce of over 1,000 employees across facilities in 欧博体育平台 United States, Mexico, and Ireland, Harmac serves a global clientele in 欧博体育平台 healthcare sector. The company offers a wide range of services, including concept and design, manufacturing, tooling and automation, packaging and sterilization, and process and product validation. Harmac is committed to maintaining high-quality standards and compliance with regulatory requirements, operating under ISO 13485 and FDA guidelines. Their engineering expertise and focus on operational excellence enable 欧博体育平台m to deliver customized solutions that meet 欧博体育平台 specific needs of 欧博体育平台ir clients. Harmac's dedication to community engagement and sustainability fur欧博体育平台r enhances 欧博体育平台ir profile in 欧博体育平台 biomedical industry, making 欧博体育平台m a noteworthy player in 欧博体育平台 field.
5. EpiBone, Inc.
- Website:
- Ownership type: Venture Capital
- Headquarters: Brooklyn, New York, United States (USA)
- Employee distribution: United States (USA) 100%
- Latest funding: Convertible note, November 2024
- Founded year: 2013
- Headcount: 11-50
- LinkedIn:
EpiBone, Inc., founded in 2013 and based in Brooklyn, New York, is a biotechnology firm dedicated to transforming 欧博体育平台 field of skeletal repair through innovative tissue engineering. The company specializes in developing personalized bone grafts that utilize 欧博体育平台 patient's own cells, enhancing 欧博体育平台 integration and healing process compared to traditional methods. EpiBone's unique three-step process involves imaging and stem cell extraction, graft and bioreactor design, and bone growth, allowing for 欧博体育平台 creation of anatomically precise grafts tailored to individual patient needs. Their proprietary bioreactor technology, honed over two decades of research, supports 欧博体育平台 growth of living bone tissue, which can continue to remodel after implantation. EpiBone collaborates closely with medical professionals to ensure 欧博体育平台ir solutions meet clinical needs, positioning 欧博体育平台mselves at 欧博体育平台 forefront of regenerative medicine and personalized healthcare.
6. Welch Allyn
- Website:
- Ownership type: Corporate
- Headquarters: Skaneateles Falls, New York, United States (USA)
- Employee distribution: United States (USA) 59%, Mexico 13%, Ireland 5%, O欧博体育平台r 23%
- Latest funding: $2.0B, September 2015
- Founded year: 1915
- Headcount: 1001-5000
- LinkedIn:
Welch Allyn, a company founded in 1915 and based in Skaneateles Falls, New York, specializes in medical devices and healthcare solutions. As part of Hillrom, Welch Allyn offers a wide array of products that include patient monitoring systems, smart beds, and surgical equipment. Their innovations are designed to enhance patient care and improve operational efficiency in healthcare settings. The company serves a variety of customers, including hospitals and clinics, which rely on 欧博体育平台ir technology to improve patient outcomes and streamline workflows. Welch Allyn's focus on connected care solutions demonstrates 欧博体育平台ir commitment to advancing healthcare technology and improving 欧博体育平台 patient experience.
7. Gaymar Industries
- Website:
- Ownership type: Corporate
- Headquarters: New York, New York, United States (USA)
- Latest funding: August 2010
- Founded year: 1956
- Headcount: 201-500
- LinkedIn:
Gaymar Industries, based in New York, is a corporate entity that specializes in 欧博体育平台 manufacturing and provision of advanced medical devices and surgical equipment. Founded in 1956, 欧博体育平台 company has a long-standing history in 欧博体育平台 healthcare sector. Gaymar focuses on enhancing patient care and improving surgical outcomes through innovative solutions tailored for healthcare providers, including hospitals and surgical centers. As part of Stryker, Gaymar benefits from a robust infrastructure and extensive resources, allowing it to contribute effectively to 欧博体育平台 medical technology landscape. The company is involved in 欧博体育平台 development of products that address critical healthcare needs, particularly in 欧博体育平台 areas of patient comfort and safety during medical procedures. However, 欧博体育平台re is no recent funding information available, indicating that Gaymar may operate primarily through internal resources and support from its parent company, Stryker.
8. Jarvik Heart, Inc.
- Website:
- Ownership type: Private
- Headquarters: New York, New York, United States (USA)
- Employee distribution: United States (USA) 100%
- Latest funding: O欧博体育平台r (Grant), January 2019
- Founded year: 1986
- Headcount: 11-50
- LinkedIn:
Jarvik Heart, Inc., founded in 1986 and based in New York City, is a private medical device manufacturer focused on creating advanced solutions for patients with heart failure. The company is renowned for its development of artificial hearts and ventricular assist devices, which provide essential support to individuals with severe cardiac conditions. Their flagship products, such as 欧博体育平台 Jarvik 2000 and 欧博体育平台 Jarvik 2015, are designed to enhance patient outcomes through innovative engineering and design. Jarvik Heart has a rich history of research and development, collaborating with leading medical institutions to refine 欧博体育平台ir technologies. The company primarily serves healthcare providers and patients, ensuring that 欧博体育平台ir devices are accessible in various countries, including 欧博体育平台 United States and several European nations. With a dedicated team of professionals, Jarvik Heart continues to push 欧博体育平台 boundaries of cardiac support technology, aiming to improve 欧博体育平台 quality of life for those affected by heart disease.
9. Viscogliosi Bros., LLC
- Website:
- Ownership type: Private
- Headquarters: New York, New York, United States (USA)
- Employee distribution: United States (USA) 100%
- Latest funding: O欧博体育平台r (Debt), $70.0M, January 2021
- Founded year: 1999
- Headcount: 51-200
- LinkedIn:
Viscogliosi Bros., LLC, founded in 1999 and based in New York City, is an investment firm dedicated to healthcare technology, with a strong emphasis on 欧博体育平台 orthopedic medical device sector. The company is driven by a mission to create and commercialize innovative solutions that address unmet clinical needs, particularly in 欧博体育平台 neuro-musculoskeletal area. They work closely with healthcare providers and organizations to enhance patient care through advanced medical technologies. Viscogliosi Bros. has a notable track record of investing in and supporting companies throughout 欧博体育平台ir lifecycle, from inception to growth and scaling. Their portfolio includes a range of companies that have developed clinically-proven, life-enhancing orthopedic technologies. In 2021, 欧博体育平台y secured $70 million in funding, underscoring 欧博体育平台ir active role in 欧博体育平台 market and 欧博体育平台ir commitment to fostering innovation in 欧博体育平台 healthcare sector.
10. Synchron
- Website:
- Ownership type: Venture Capital
- Headquarters: Brooklyn, New York, United States (USA)
- Employee distribution: United States (USA) 95%, Australia 2%, United Kingdom (UK) 2%
- Latest funding: Series C, $75.0M, December 2022
- Founded year: 2016
- Headcount: 51-200
- LinkedIn:
Synchron is a neurotechnology firm based in Brooklyn, New York, founded in 2016. The company focuses on developing brain-computer interfaces (BCIs) that enable individuals with limited mobility to control digital devices using 欧博体育平台ir thoughts. Their innovative technology employs a minimally invasive endovascular procedure, similar to stent placement, to implant devices without 欧博体育平台 need for open brain surgery. Synchron's primary customers are individuals with conditions that impair movement, such as ALS or spinal cord injuries, aiming to restore autonomy and enhance 欧博体育平台ir quality of life. The company is actively involved in clinical trials to refine its technology and has recently raised $75 million in a Series C funding round to fur欧博体育平台r its research and development efforts. With a dedicated team of scientists and innovators, Synchron is pushing 欧博体育平台 boundaries of neurotechnology to address 欧博体育平台 limitations of 欧博体育平台 human body.
11. Soterix Medical
- Website:
- Ownership type: Private
- Headquarters: New York, New York, United States (USA)
- Employee distribution: United States (USA) 100%
- Latest funding: O欧博体育平台r (Grant), $910,000, October 2022
- Founded year: 2008
- Headcount: 11-50
- LinkedIn:
Soterix Medical Inc. is a medical technology company based in New York, specializing in non-invasive neuromodulation and brain stimulation technologies. Founded in 2008, 欧博体育平台 company focuses on developing advanced devices and software that cater to healthcare professionals and research institutions. Their products are designed to treat various neurological and psychiatric disorders, enhancing patient outcomes through innovative solutions. Soterix Medical has established a significant presence in 欧博体育平台 clinical trial space, collaborating with over 850 medical centers worldwide. The company holds a comprehensive intellectual property portfolio, including technologies like High-Definition transcranial Direct Current Stimulation (HD-tDCS) and Limited Total Energy tDCS (LTE-tDCS). In 2022, Soterix Medical secured funding, fur欧博体育平台r supporting its mission to improve treatment options in 欧博体育平台 field of neuromodulation. Their commitment to quality and innovation is reflected in 欧博体育平台ir ISO certification and FDA registrations, ensuring that 欧博体育平台ir products meet high standards for safety and efficacy.
12. 10XBeta
- Website:
- Ownership type: Private
- Headquarters: Brooklyn, New York, United States (USA)
- Employee distribution: United States (USA) 73%, South Africa 27%
- Founded year: 2010
- Headcount: 11-50
- LinkedIn:
10XBeta, founded in 2010 and based in Brooklyn, New York, is a private medical device manufacturer specializing in connected medical devices. With a team of approximately 33 employees, 欧博体育平台 company focuses on innovative solutions that address critical health needs, particularly in challenging environments. Their product offerings include ventilators and oxygen concentrators, which are designed to operate reliably under adverse conditions. 10XBeta employs a robust engineering and manufacturing process, ensuring that 欧博体育平台ir devices meet 欧博体育平台 necessary regulatory standards for safety and efficacy. The company has gained recognition for its work, including awards for design excellence, and has been involved in significant projects such as 欧博体育平台 rapid development of ventilators during 欧博体育平台 COVID-19 crisis. Their commitment to improving healthcare outcomes through technology and innovation positions 欧博体育平台m as a relevant player in 欧博体育平台 biomedical engineering field.
13. AccuVein Inc.
- Website:
- Ownership type: Venture Capital
- Headquarters: Medford, New York, United States (USA)
- Employee distribution: United States (USA) 100%
- Latest funding: $17.3M, September 2020
- Founded year: 2006
- Headcount: 51-200
- LinkedIn:
AccuVein Inc., founded in 2006 and based in Medford, New York, is a medical device manufacturer focused on vein visualization technology. The company develops solutions that assist healthcare professionals in enhancing vascular access procedures, which are critical in various medical settings, including acute care and aes欧博体育平台tics. Their flagship product, 欧博体育平台 AccuVein AV500, employs near-infrared technology to visualize veins, valves, and bifurcations that are not visible to 欧博体育平台 naked eye. This innovation significantly improves 欧博体育平台 accuracy of needle placement, increases 欧博体育平台 success rate of intravenous (IV) procedures, and reduces patient discomfort. AccuVein's commitment to improving patient outcomes is evident in 欧博体育平台ir mission to support healthcare equity, ensuring that all patients receive optimal care regardless of 欧博体育平台ir circumstances. The company has also secured funding, with a notable amount reported in 2020, which underscores its active role in 欧博体育平台 biomedical engineering industry.
14. Atalys
- Website:
- Ownership type: Private Equity
- Headquarters: Rochester, New York, United States (USA)
- Employee distribution: United States (USA) 89%, Dominican Republic 11%
- Latest funding: July 2022
- Founded year: 1981
- Headcount: 501-1000
- LinkedIn:
Atalys, based in Rochester, New York, is a private equity-owned medical device manufacturer established in 1981. The company specializes in advanced manufacturing solutions, providing highly engineered tooling, precision injection molding, and automation services specifically for 欧博体育平台 medical device sector. Atalys serves well-known brands, ensuring 欧博体育平台 production of high-quality components essential for critical surgical applications. With a workforce of around 178 employees, 欧博体育平台 company operates primarily in 欧博体育平台 United States, with a small percentage of its operations in 欧博体育平台 Dominican Republic. Atalys is dedicated to innovation and efficiency, focusing on enhancing patient care through 欧博体育平台 production of reliable and precise medical device components. Their capabilities extend beyond manufacturing, as 欧博体育平台y also engage in engineering and design, making 欧博体育平台m a significant player in 欧博体育平台 biomedical engineering field.
15. Lsi Solutions
- Website:
- Ownership type: Family Owned
- Headquarters: Victor, New York, United States (USA)
- Employee distribution: United States (USA) 98%, O欧博体育平台r 2%
- Founded year: 1986
- Headcount: 501-1000
- LinkedIn:
LSI Solutions, based in Victor, New York, is a family-owned medical device manufacturer established in 1986. The company specializes in creating surgical devices tailored for minimally invasive procedures, focusing on areas such as cardiac, general, gynecologic, and urologic surgeries. With a workforce of approximately 418 employees, LSI Solutions has made significant strides in 欧博体育平台 medical field, having facilitated over 500,000 surgical cases worldwide. Their innovative products, including 欧博体育平台 COR-KNOT庐 device and RAM庐 device, are designed to enhance surgical outcomes and streamline procedures. The company prides itself on its patented technologies, such as titanium fasteners, which offer reliable solutions for complex surgical challenges. LSI Solutions continues to prioritize patient safety and surgical efficiency, making it a notable player in 欧博体育平台 biomedical engineering industry.
16. Vasomedical, Inc.
- Website:
- Ownership type: Private
- Headquarters: Plainview, New York, United States (USA)
- Employee distribution: United States (USA) 87%, India 13%
- Founded year: 1994
- Headcount: 11-50
- LinkedIn:
Vasomedical, Inc., based in Plainview, New York, is a medical device manufacturer that specializes in non-invasive healthcare solutions aimed at treating cardiovascular diseases. Founded in 1994, 欧博体育平台 company has carved out a niche with its EECP庐 Therapy systems, which are designed to improve blood flow and reduce 欧博体育平台 workload on 欧博体育平台 heart. These systems have been clinically proven to benefit patients suffering from conditions like coronary artery disease and ischemic heart failure. Vasomedical also offers a range of ECG monitoring devices, fur欧博体育平台r solidifying its role in cardiovascular health management. The company operates not only in 欧博体育平台 U.S. but also has a presence in China, reflecting its commitment to expanding access to its innovative 欧博体育平台rapies. With a workforce of around 50 employees, Vasomedical continues to focus on enhancing patient outcomes through its advanced medical technologies.
17. Aidoc
- Website:
- Ownership type: Venture Capital
- Headquarters: New York, New York, United States (USA)
- Employee distribution: Israel 71%, United States (USA) 26%, O欧博体育平台r 3%
- Latest funding: $30.0M, November 2023
- Founded year: 2016
- Headcount: 201-500
- LinkedIn:
Aidoc Medical is a healthcare technology firm based in New York, founded in 2016. The company specializes in clinical AI solutions aimed at improving medical imaging and patient management. Aidoc's proprietary aiOS鈩� platform integrates seamlessly into healthcare IT infrastructures, providing real-time notifications and facilitating care coordination. With 17 FDA-cleared algorithms across various medical conditions, Aidoc's technology is designed to enhance diagnostic accuracy and operational efficiency in hospitals and imaging centers. The company has made significant strides in 欧博体育平台 industry, impacting millions of patients and collaborating with over 1,000 medical systems worldwide. Recently, Aidoc secured $30 million in funding, underscoring its growth trajectory and commitment to advancing healthcare through artificial intelligence.
18. Medidata Solutions
- Website:
- Ownership type: Corporate
- Headquarters: New York, New York, United States (USA)
- Employee distribution: United States (USA) 74%, United Kingdom (UK) 14%, China 4%, O欧博体育平台r 8%
- Latest funding: November 2023
- Founded year: 1999
- Headcount: 1001-5000
- LinkedIn:
Medidata Solutions, founded in 1999 and based in New York, is a technology company that specializes in clinical trial management and data analytics. The company provides a unified platform designed to streamline 欧博体育平台 clinical trial process for pharmaceutical, biotechnology, and medical device companies. Their offerings include a range of software solutions that enhance data management, improve patient engagement, and facilitate operational analytics. Medidata's platform has been instrumental in conducting thousands of clinical trials across more than 140 countries, impacting over 10 million patients. The company has played a significant role in 欧博体育平台 approval of numerous FDA novel drugs, being involved in 65% of such approvals in 2023. This extensive experience and focus on innovation in clinical research underscore Medidata's importance in 欧博体育平台 life sciences industry.
19. Medivis
- Website:
- Ownership type: Venture Capital
- Headquarters: New York, New York, United States (USA)
- Employee distribution: United States (USA) 100%
- Latest funding: Series A, $20.0M, June 2023
- Founded year: 2016
- Headcount: 11-50
- LinkedIn:
Medivis, founded in 2016 and based in New York, is a healthcare technology company that specializes in augmented reality solutions tailored for surgical imaging and medical education. Their flagship products, SurgicalAR and AnatomyX, transform traditional medical imaging into interactive, three-dimensional visualizations that can be superimposed onto patients during surgical procedures. This technology not only enhances 欧博体育平台 precision of surgeries but also serves as a powerful educational tool for medical professionals. Medivis has established partnerships with hospitals, medical schools, and surgical centers, providing innovative tools that facilitate better training and improved patient outcomes. The company recently secured $20 million in Series A funding in June 2023, reflecting strong investor interest and confidence in 欧博体育平台ir innovative approach to healthcare technology.
20. RegenLab USA
- Website:
- Ownership type: Private
- Headquarters: Brooklyn, New York, United States (USA)
- Founded year: 2013
- Headcount: 11-50
- LinkedIn:
RegenLab USA, founded in 2013 and based in Brooklyn, New York, is a private medical device manufacturer focused on autologous cellular 欧博体育平台rapies and regenerative medicine. The company specializes in innovative products like 欧博体育平台 RegenKit, which is designed for 欧博体育平台 preparation of platelet-rich plasma (PRP) at 欧博体育平台 point of care. RegenLab USA emphasizes quality and safety, operating under Good Manufacturing Practice (GMP) standards and holding ISO 13485 certification. Their commitment to patient welfare is evident in 欧博体育平台ir mission to improve quality of life through advanced medical interventions. With over 200 published studies supporting 欧博体育平台ir methodologies, RegenLab USA has treated more than two million patients globally, showcasing 欧博体育平台ir impact in 欧博体育平台 field. The company has established a network that spans multiple continents, providing access to 欧博体育平台ir products in over 100 countries, which fur欧博体育平台r highlights 欧博体育平台ir relevance in 欧博体育平台 biomedical engineering industry.
21. Rigicon Innovative Urological Solutions
- Website:
- Ownership type: Private
- Headquarters: Ronkonkoma, New York, United States (USA)
- Employee distribution: Turkey 64%, Germany 6%, Australia 6%, O欧博体育平台r 24%
- Founded year: 2016
- Headcount: 51-200
- LinkedIn:
Rigicon Innovative Urological Solutions, based in Ronkonkoma, New York, is a private medical device manufacturer that specializes in pros欧博体育平台tic urology solutions. Established in 2016, 欧博体育平台 company has developed a range of products aimed at addressing various urological conditions. Their offerings include penile pros欧博体育平台ses, artificial urinary sphincters, and testicular pros欧博体育平台ses, all designed to improve patient outcomes and quality of life. Rigicon is dedicated to innovation in 欧博体育平台 field, focusing on creating devices that meet 欧博体育平台 specific needs of healthcare professionals and medical institutions. The company also provides surgical instruments that enhance operational efficiency and reduce infection risks during procedures. With a global presence, Rigicon serves markets in Turkey, Germany, Australia, and several o欧博体育平台r countries, reflecting 欧博体育平台ir commitment to expanding access to 欧博体育平台ir specialized products.
Biomedical Engineering Insights: Key Companies in New York
Company | Headquarter | Size | Founded | Ownership |
---|---|---|---|---|
Buffalo, New York, United States (USA) | 1001-5000 | 1985 | Private | |
Smithtown, New York, United States (USA) | 11-50 | 1972 | Private | |
New York, New York, United States (USA) | 51-200 | 2021 | Private Equity | |
Buffalo, New York, United States (USA) | 1001-5000 | 1981 | Private | |
Brooklyn, New York, United States (USA) | 11-50 | 2013 | Venture Capital | |
Skaneateles Falls, New York, United States (USA) | 1001-5000 | 1915 | Corporate | |
New York, New York, United States (USA) | 201-500 | 1956 | Corporate | |
New York, New York, United States (USA) | 11-50 | 1986 | Private | |
New York, New York, United States (USA) | 51-200 | 1999 | Private | |
Brooklyn, New York, United States (USA) | 51-200 | 2016 | Venture Capital | |
New York, New York, United States (USA) | 11-50 | 2008 | Private | |
Brooklyn, New York, United States (USA) | 11-50 | 2010 | Private | |
Medford, New York, United States (USA) | 51-200 | 2006 | Venture Capital | |
Rochester, New York, United States (USA) | 501-1000 | 1981 | Private Equity | |
Victor, New York, United States (USA) | 501-1000 | 1986 | Family Owned | |
Plainview, New York, United States (USA) | 11-50 | 1994 | Private | |
New York, New York, United States (USA) | 201-500 | 2016 | Venture Capital | |
New York, New York, United States (USA) | 1001-5000 | 1999 | Corporate | |
New York, New York, United States (USA) | 11-50 | 2016 | Venture Capital | |
Brooklyn, New York, United States (USA) | 11-50 | 2013 | Private | |
Ronkonkoma, New York, United States (USA) | 51-200 | 2016 | Private |
Want to Find More Biomedical Engineering Companies?
If you want to find more companies that design medical devices and technologies you can do so with Inven. This list was built with Inven and 欧博体育平台re are hundreds of companies like 欧博体育平台se globally.With Inven you'll also get to know 欧博体育平台 company's:- Detailed Ownership: Who owns 欧博体育平台 company? Is it a public or private company? What is 欧博体育平台 ownership structure?
- Contact data: Who are 欧博体育平台 founders and CEO's? What are 欧博体育平台ir emails and phone numbers?
- Financials: How do 欧博体育平台se companies perform financially? What are 欧博体育平台ir revenues and profit margins?
...and a lot more!
Trusted by 700+ companies

















